. Author manuscript; available in PMC: 2018 Jan 15.

Published in final edited form as: J Immunol. 2016 Nov 30;198(2):895–907. doi: 10.4049/jimmunol.1601448

Table 1.

Quantitative analysis of CD3⁺ and CD3⁻ cytokine-producing cells in tracheal and lung tissue sections¹

n=3 mice	% of IL-13⁺ cells (out of total CD3⁺ T cells) ± SEM	% of IL-17⁺ cells (out of total CD3⁺ T cells) ± SEM	# of CD3⁻ cells / total IL-13⁺ cells (percent)	# of CD3⁻ cells / total IL-17⁺ cells (percent)
Trachea	1.59 ± 0.11%	1.06 ± 0.24%	1/53 (1,89%)	0/48 (0%)
Lung	0.98 ± 0.30%	1.93 ± 0.51%	4/285 (1.4%)	8/565 (1.42%)

C57Bl/6 mice were treated with HDM/CT o.ph. on d0 and received HDM o.ph. challenge on d7. Tracheas and lungs were analyzed on d9. IL-17⁺ or IL-13⁺ cells were manually identified and co-staining for CD3 was determined. Tissue samples from 3 mice were analyzed.